Literature DB >> 20974672

Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity.

Kathleen D Metzler1, Tobias A Fuchs, William M Nauseef, Dominique Reumaux, Joachim Roesler, Ilka Schulze, Volker Wahn, Venizelos Papayannopoulos, Arturo Zychlinsky.   

Abstract

The granule enzyme myeloperoxidase (MPO) plays an important role in neutrophil antimicrobial responses. However, the severity of immunodeficiency in patients carrying mutations in MPO is variable. Serious microbial infections, especially with Candida species, have been observed in a subset of completely MPO-deficient patients. Here we show that neutrophils from donors who are completely deficient in MPO fail to form neutrophil extracellular traps (NETs), indicating that MPO is required for NET formation. In contrast, neutrophils from partially MPO-deficient donors make NETs, and pharmacological inhibition of MPO only delays and reduces NET formation. Extracellular products of MPO do not rescue NET formation, suggesting that MPO acts cell-autonomously. Finally, NET-dependent inhibition of Candida albicans growth is compromised in MPO-deficient neutrophils. The inability to form NETs may contribute in part to the host defense defects observed in completely MPO-deficient individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974672      PMCID: PMC3035083          DOI: 10.1182/blood-2010-06-290171

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Neutrophil extracellular traps kill bacteria.

Authors:  Volker Brinkmann; Ulrike Reichard; Christian Goosmann; Beatrix Fauler; Yvonne Uhlemann; David S Weiss; Yvette Weinrauch; Arturo Zychlinsky
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

2.  Hereditary myeloperoxidase deficiency.

Authors:  P Cech; A Papathanassiou; G Boreux; P Roth; P A Miescher
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

3.  Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes.

Authors:  S J Klebanoff; C B Hamon
Journal:  J Reticuloendothel Soc       Date:  1972-08

4.  Studies on the chlorinating activity of myeloperoxidase.

Authors:  J E Harrison; J Schultz
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

5.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

6.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

7.  Genetic characterization of myeloperoxidase deficiency in Italy.

Authors:  Caterina Marchetti; Pierluigi Patriarca; G Pietro Solero; Francisco E Baralle; Maurizio Romano
Journal:  Hum Mutat       Date:  2004-05       Impact factor: 4.878

8.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

9.  Myeloperoxidase-halide-hydrogen peroxide antibacterial system.

Authors:  S J Klebanoff
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

10.  Myeloperoxidase deficiency: prevalence and clinical significance.

Authors:  M F Parry; R K Root; J A Metcalf; K K Delaney; L S Kaplow; W J Richar
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391

View more
  237 in total

1.  Antiinflammatory properties of antiLy6G antibody disappear during magnetic field exposure in rats with carrageenan induced acute paw inflammation.

Authors:  Tufan Mert; Tuba Ozcan Metin; Mehmet Sahin; Selma Yaman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-26       Impact factor: 3.000

2.  Toxoplasma gondii triggers release of human and mouse neutrophil extracellular traps.

Authors:  Delbert S Abi Abdallah; Changyou Lin; Carissa J Ball; Michael R King; Gerald E Duhamel; Eric Y Denkers
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

3.  Editorial: Nyet to NETs? A pause for healthy skepticism.

Authors:  William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-03       Impact factor: 4.962

Review 4.  Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: Recent Experimental and Clinical Insights.

Authors:  Yvonne Döring; Peter Libby; Oliver Soehnlein
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 5.  Myeloperoxidase: A new player in autoimmunity.

Authors:  Anna Strzepa; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Cell Immunol       Date:  2017-05-10       Impact factor: 4.868

6.  Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression.

Authors:  M Jaganjac; M Poljak-Blazi; R J Schaur; K Zarkovic; S Borovic; A Cipak; M Cindric; K Uchida; G Waeg; N Zarkovic
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

Review 7.  It takes a village: Phagocytes play a central role in fungal immunity.

Authors:  Michael B Feldman; Jatin M Vyas; Michael K Mansour
Journal:  Semin Cell Dev Biol       Date:  2018-06-12       Impact factor: 7.727

Review 8.  Extracellular DNA and autoimmune diseases.

Authors:  Hantao Lou; Matthew C Pickering
Journal:  Cell Mol Immunol       Date:  2018-03-19       Impact factor: 11.530

9.  Bacterial Siderophores Hijack Neutrophil Functions.

Authors:  Piu Saha; Beng San Yeoh; Rodrigo A Olvera; Xia Xiao; Vishal Singh; Deepika Awasthi; Bhagawat C Subramanian; Qiuyan Chen; Madhu Dikshit; Yanming Wang; Carole A Parent; Matam Vijay-Kumar
Journal:  J Immunol       Date:  2017-04-21       Impact factor: 5.422

10.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.